Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration

Cardiovascular Research

Volumn 93, Issue 3, 2012, Pages 406-413

  Jagadeesha, Dammanahalli K ^a   Takapoo, Maysam ^b   Banfi, Botond ^a   Bhalla, Ramesh C ^a   Miller, Francis J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidermal growth factor receptor; Matrix metalloproteinase; N cadherin; NADPH oxidase; Smooth muscle cells

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; THROMBIN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; THORACIC AORTA;

EID: 84857546522     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr308     Document Type: Article

References (40)

1. Schwartz SM, de Blois D, O'Brien ERM. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465.
2. George SJ, Beeching CA. Cadherin: catenin complex: a novel regulator of vascular smooth muscle cell behaviour. Atherosclerosis 2006;188:1-11.
3. Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC et al. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 2003;92:1314-1321.
4. Slater SC, Koutsouki E, Jackson CL, Bush RC, Angelini GD, Newby AC et al. R-Cadherin:{beta}-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 2004;24:1204.
5. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res 2006;99:1329-1337.
6. Jones M, Sabatini PJB, Lee FSH, Bendeck MP, Langille BL. N-cadherin upregulation and function in response of smooth muscle cells to arterial injury. Arterioscler Thromb Vasc Biol 2002;22:1972.
7. Blindt R, Bosserhoff AK, Dammers J, Krott N, Demircan L, Hoffmann R et al. Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation. Cardiovasc Res 2004;62:212-222.
8. Lyon CA, Koutsouki E, Aguilera CM, Blaschuk OW, George SJ. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis. J Vasc Surg 2010;52:1301-1309.
9. Gallo R, Padurean A, Toschi V, Bichler J, Fallon JT, Chesebro JH et al. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 1998;97:581-588.
10. Brandes RP, Viedt C, Nguyen K, Beer S, Kreuzer J, Busse R et al. Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells. Thromb Haemost 2001;85:1104-1110.
11. Miller FJ Jr, Chu X, Stanic B, Tian X, Sharma RV, Davisson RL et al. A differential role for endocytosis in receptor-mediated activation of Nox1. Antioxid Redox Signal 2010;12:583-593.
12. Chan AK, Kalmes A, Hawkins S, Daum G, Clowes AW. Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg 2003;37:644-649.
13. Lee MY, Martin AS, Mehta PK, Dikalova AE, Garrido AM, Datla SR et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009;29:480-487.
14. Hirano K, Kanaide H. Role of protease-activated receptors in the vascular system. J Atheroscler Thromb 2003;10:211-225.
15. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-868.
16. Bendeck M, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994;75:539-545.
17. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999;85:1179-1185.
18. Jones GT, Kay IP, Chu JWS, Wilkins GT, Phillips LV, McCormick M et al. Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis. Arterioscler Thromb Vasc Biol 2006;26:e121.
19. Dwivedi A, Slater SC, George SJ. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 2009;81:178-186.
20. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F et al. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 2006;580:497-504.
21. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998;82:1298-1305.
22. Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Berry MF, Burdick J et al. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation 2004;110:II180-II186.
23. Miller FJ Jr, Filali M, Huss GJ, Stanic B, Chamseddine A, Barna TJ et al. Cytokine activation of nuclear factor-kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res 2007;101:663-671.
24. Stanic B, Katsuyama M, Miller FJ Jr. An oxidized extracellular redox state increases Nox1 expression and proliferation in vascular smooth muscle cells via EGFR activation. Arterio Thromb Vasc Biol 2010;30:2234-2241.
25. Gurjar MV, Deleon J, Sharma RV, Bhalla RC. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am J Physiol Heart Circ Physiol 2001;281:H2568-H2574.
26. Seidel CL, Helgason T, Allen JC, Wilson C. Migratory abilities of different vascular cells from the tunica media of canine vessels. Am J Physiol 1997;272:C847-C852.
27. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:489-495.
28. Dong J, Ramachandiran S, Tikoo K, Jia Z, Lau SS, Monks TJ. EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death. Am J Physiol Renal Physiol 2004;287:1049-1058.
29. Sancho P, Fabregat I. NADPH oxidase NOX1 controls autocrine growth of liver tumor cells through up-regulation of the epidermal growth factor receptor pathway. J Biol Chem 2010;285:24815-24824.
30. Dollery CM, Humphries SE, McClelland A, Latchman DS, McEwan JR. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 1999;99:3199-3205.
31. Forough R, Koyama N, Hasenstab D, Lea H, Clowes M, Nikkari ST et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 1996;79:812-820.
32. George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther 1998;9:867-877.
33. Jackson CL, Pettersson KS. Effects of probucol on rat carotid artery responses to balloon catheter injury. Atherosclerosis 2001;154:407-414.
34. Jagadeesha DK, Lindley TE, Deleon J, Sharma RV, Miller F, Bhalla RC. Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. Am J Physiol Heart Circ Physiol 2005;289:H1047-H1053.
35. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL et al. Upregulation of Nox-based NAD (P) H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002;22:21-27.
36. Schroder K, Helmcke I, Palfi K, Krause KH, Busse R, Brandes RP. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007;27:1736-1743.
37. Luttrell LM, Daaka Y, Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 1999;11:177-183.
38. Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 2001;8:11-31.
39. Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M et al. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun. NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res 2001;88:1120-1126.
40. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler, Thromb Vasc Biol 2003;23:795-801.